IBDEI03J ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4360,1,4,0)
 ;;=4^TARSAL TUNNEL SYNDROME
 ;;^UTILITY(U,$J,358.3,4360,2)
 ;;=^117247
 ;;^UTILITY(U,$J,358.3,4361,0)
 ;;=355.6^^39^353^29
 ;;^UTILITY(U,$J,358.3,4361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4361,1,3,0)
 ;;=3^355.6
 ;;^UTILITY(U,$J,358.3,4361,1,4,0)
 ;;=4^PLANTAR NERVE LESION
 ;;^UTILITY(U,$J,358.3,4361,2)
 ;;=^268517
 ;;^UTILITY(U,$J,358.3,4362,0)
 ;;=355.71^^39^353^3
 ;;^UTILITY(U,$J,358.3,4362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4362,1,3,0)
 ;;=3^355.71
 ;;^UTILITY(U,$J,358.3,4362,1,4,0)
 ;;=4^CAUSALGIA OF LL
 ;;^UTILITY(U,$J,358.3,4362,2)
 ;;=^295729
 ;;^UTILITY(U,$J,358.3,4363,0)
 ;;=355.79^^39^353^26
 ;;^UTILITY(U,$J,358.3,4363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4363,1,3,0)
 ;;=3^355.79
 ;;^UTILITY(U,$J,358.3,4363,1,4,0)
 ;;=4^OTHER MONONEURITIS OF LL
 ;;^UTILITY(U,$J,358.3,4363,2)
 ;;=^268518
 ;;^UTILITY(U,$J,358.3,4364,0)
 ;;=355.8^^39^353^18
 ;;^UTILITY(U,$J,358.3,4364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4364,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,4364,1,4,0)
 ;;=4^MONONEURITIS LEG NOS
 ;;^UTILITY(U,$J,358.3,4364,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,4365,0)
 ;;=355.9^^39^353^20
 ;;^UTILITY(U,$J,358.3,4365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4365,1,3,0)
 ;;=3^355.9
 ;;^UTILITY(U,$J,358.3,4365,1,4,0)
 ;;=4^MONONEURITIS NOS
 ;;^UTILITY(U,$J,358.3,4365,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,4366,0)
 ;;=357.2^^39^353^30
 ;;^UTILITY(U,$J,358.3,4366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4366,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,4366,1,4,0)
 ;;=4^POLYNEUROPATHY IN DIABETES
 ;;^UTILITY(U,$J,358.3,4366,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,4367,0)
 ;;=353.0^^39^353^1
 ;;^UTILITY(U,$J,358.3,4367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4367,1,3,0)
 ;;=3^353.0
 ;;^UTILITY(U,$J,358.3,4367,1,4,0)
 ;;=4^BRACHIAL PLEXUS LESIONS
 ;;^UTILITY(U,$J,358.3,4367,2)
 ;;=^16605
 ;;^UTILITY(U,$J,358.3,4368,0)
 ;;=353.2^^39^353^5
 ;;^UTILITY(U,$J,358.3,4368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4368,1,3,0)
 ;;=3^353.2
 ;;^UTILITY(U,$J,358.3,4368,1,4,0)
 ;;=4^CERVICAL ROOT LESION NEC
 ;;^UTILITY(U,$J,358.3,4368,2)
 ;;=^268498
 ;;^UTILITY(U,$J,358.3,4369,0)
 ;;=353.4^^39^353^14
 ;;^UTILITY(U,$J,358.3,4369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4369,1,3,0)
 ;;=3^353.4
 ;;^UTILITY(U,$J,358.3,4369,1,4,0)
 ;;=4^LUMBSACRAL ROOT LESIONS NEC
 ;;^UTILITY(U,$J,358.3,4369,2)
 ;;=^268501
 ;;^UTILITY(U,$J,358.3,4370,0)
 ;;=353.5^^39^353^23
 ;;^UTILITY(U,$J,358.3,4370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4370,1,3,0)
 ;;=3^353.5
 ;;^UTILITY(U,$J,358.3,4370,1,4,0)
 ;;=4^NEURALGIC AMYOTROPHY
 ;;^UTILITY(U,$J,358.3,4370,2)
 ;;=^21928
 ;;^UTILITY(U,$J,358.3,4371,0)
 ;;=353.6^^39^353^28
 ;;^UTILITY(U,$J,358.3,4371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4371,1,3,0)
 ;;=3^353.6
 ;;^UTILITY(U,$J,358.3,4371,1,4,0)
 ;;=4^PHANTOM LIMB (SYNDROME)
 ;;^UTILITY(U,$J,358.3,4371,2)
 ;;=^92758
 ;;^UTILITY(U,$J,358.3,4372,0)
 ;;=353.8^^39^353^24
 ;;^UTILITY(U,$J,358.3,4372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4372,1,3,0)
 ;;=3^353.8
 ;;^UTILITY(U,$J,358.3,4372,1,4,0)
 ;;=4^OTH NERVE ROOT/PLEXUS DIS NEC
 ;;^UTILITY(U,$J,358.3,4372,2)
 ;;=^268502
 ;;^UTILITY(U,$J,358.3,4373,0)
 ;;=353.9^^39^353^37
 ;;^UTILITY(U,$J,358.3,4373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4373,1,3,0)
 ;;=3^353.9
 ;;^UTILITY(U,$J,358.3,4373,1,4,0)
 ;;=4^UNSPEC NERVE ROOT/PLEXUS DIS NOS
 ;;^UTILITY(U,$J,358.3,4373,2)
 ;;=^268503
 ;;^UTILITY(U,$J,358.3,4374,0)
 ;;=356.0^^39^353^9
 ;;^UTILITY(U,$J,358.3,4374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4374,1,3,0)
 ;;=3^356.0
 ;;^UTILITY(U,$J,358.3,4374,1,4,0)
 ;;=4^HERED PERIPH NEUROPATHY
 ;;^UTILITY(U,$J,358.3,4374,2)
 ;;=^268520
 ;;^UTILITY(U,$J,358.3,4375,0)
 ;;=356.1^^39^353^27
 ;;^UTILITY(U,$J,358.3,4375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4375,1,3,0)
 ;;=3^356.1
 ;;^UTILITY(U,$J,358.3,4375,1,4,0)
 ;;=4^PERONEAL MUSCLE ATROPHY
 ;;^UTILITY(U,$J,358.3,4375,2)
 ;;=^22244
 ;;^UTILITY(U,$J,358.3,4376,0)
 ;;=356.2^^39^353^10
 ;;^UTILITY(U,$J,358.3,4376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4376,1,3,0)
 ;;=3^356.2
 ;;^UTILITY(U,$J,358.3,4376,1,4,0)
 ;;=4^HERED SENSORY NEUROPATHY
 ;;^UTILITY(U,$J,358.3,4376,2)
 ;;=^56583
 ;;^UTILITY(U,$J,358.3,4377,0)
 ;;=356.3^^39^353^32
 ;;^UTILITY(U,$J,358.3,4377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4377,1,3,0)
 ;;=3^356.3
 ;;^UTILITY(U,$J,358.3,4377,1,4,0)
 ;;=4^REFSUM'S DISEASE
 ;;^UTILITY(U,$J,358.3,4377,2)
 ;;=^104358
 ;;^UTILITY(U,$J,358.3,4378,0)
 ;;=356.4^^39^353^11
 ;;^UTILITY(U,$J,358.3,4378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4378,1,3,0)
 ;;=3^356.4
 ;;^UTILITY(U,$J,358.3,4378,1,4,0)
 ;;=4^IDIO PROG POLYNEUROPATHY
 ;;^UTILITY(U,$J,358.3,4378,2)
 ;;=^268523
 ;;^UTILITY(U,$J,358.3,4379,0)
 ;;=356.8^^39^353^25
 ;;^UTILITY(U,$J,358.3,4379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4379,1,3,0)
 ;;=3^356.8
 ;;^UTILITY(U,$J,358.3,4379,1,4,0)
 ;;=4^OTH SPEC IDIOPATHIC PER NEURO
 ;;^UTILITY(U,$J,358.3,4379,2)
 ;;=^268525
 ;;^UTILITY(U,$J,358.3,4380,0)
 ;;=356.9^^39^353^36
 ;;^UTILITY(U,$J,358.3,4380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4380,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,4380,1,4,0)
 ;;=4^UNSPEC IDIOPATHIC PER NEURO
 ;;^UTILITY(U,$J,358.3,4380,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,4381,0)
 ;;=785.4^^39^354^1
 ;;^UTILITY(U,$J,358.3,4381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4381,1,3,0)
 ;;=3^785.4
 ;;^UTILITY(U,$J,358.3,4381,1,4,0)
 ;;=4^GANGRENE
 ;;^UTILITY(U,$J,358.3,4381,2)
 ;;=^49194
 ;;^UTILITY(U,$J,358.3,4382,0)
 ;;=443.81^^39^354^2
 ;;^UTILITY(U,$J,358.3,4382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4382,1,3,0)
 ;;=3^443.81
 ;;^UTILITY(U,$J,358.3,4382,1,4,0)
 ;;=4^ANGIOPATHY IN OTHER DIS
 ;;^UTILITY(U,$J,358.3,4382,2)
 ;;=^92164
 ;;^UTILITY(U,$J,358.3,4383,0)
 ;;=707.10^^39^355^1
 ;;^UTILITY(U,$J,358.3,4383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4383,1,3,0)
 ;;=3^707.10
 ;;^UTILITY(U,$J,358.3,4383,1,4,0)
 ;;=4^UNSPEC ULCER LOWER LIMB
 ;;^UTILITY(U,$J,358.3,4383,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,4384,0)
 ;;=707.11^^39^355^2
 ;;^UTILITY(U,$J,358.3,4384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4384,1,3,0)
 ;;=3^707.11
 ;;^UTILITY(U,$J,358.3,4384,1,4,0)
 ;;=4^ULCER OF THIGH
 ;;^UTILITY(U,$J,358.3,4384,2)
 ;;=^322143
 ;;^UTILITY(U,$J,358.3,4385,0)
 ;;=707.12^^39^355^3
 ;;^UTILITY(U,$J,358.3,4385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4385,1,3,0)
 ;;=3^707.12
 ;;^UTILITY(U,$J,358.3,4385,1,4,0)
 ;;=4^ULCER OF CALF
 ;;^UTILITY(U,$J,358.3,4385,2)
 ;;=^322144
 ;;^UTILITY(U,$J,358.3,4386,0)
 ;;=707.13^^39^355^4
 ;;^UTILITY(U,$J,358.3,4386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4386,1,3,0)
 ;;=3^707.13
 ;;^UTILITY(U,$J,358.3,4386,1,4,0)
 ;;=4^ULCER OF ANKLE
 ;;^UTILITY(U,$J,358.3,4386,2)
 ;;=^322145
 ;;^UTILITY(U,$J,358.3,4387,0)
 ;;=707.14^^39^355^5
 ;;^UTILITY(U,$J,358.3,4387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4387,1,3,0)
 ;;=3^707.14
 ;;^UTILITY(U,$J,358.3,4387,1,4,0)
 ;;=4^ULCER OF HEEL AND MIDFOOT
 ;;^UTILITY(U,$J,358.3,4387,2)
 ;;=^322146
 ;;^UTILITY(U,$J,358.3,4388,0)
 ;;=707.15^^39^355^6
 ;;^UTILITY(U,$J,358.3,4388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4388,1,3,0)
 ;;=3^707.15
 ;;^UTILITY(U,$J,358.3,4388,1,4,0)
 ;;=4^ULCER OF OTH PART OF FOOT
 ;;^UTILITY(U,$J,358.3,4388,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,4389,0)
 ;;=707.19^^39^355^7
 ;;^UTILITY(U,$J,358.3,4389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4389,1,3,0)
 ;;=3^707.19
 ;;^UTILITY(U,$J,358.3,4389,1,4,0)
 ;;=4^ULCER OF OTH PART LOWER LIMB
 ;;^UTILITY(U,$J,358.3,4389,2)
 ;;=^322150
 ;;^UTILITY(U,$J,358.3,4390,0)
 ;;=707.8^^39^355^8
 ;;^UTILITY(U,$J,358.3,4390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4390,1,3,0)
 ;;=3^707.8
 ;;^UTILITY(U,$J,358.3,4390,1,4,0)
 ;;=4^CHRONIC SKIN ULCER NEC
 ;;^UTILITY(U,$J,358.3,4390,2)
 ;;=^271935
 ;;^UTILITY(U,$J,358.3,4391,0)
 ;;=707.9^^39^355^9
 ;;^UTILITY(U,$J,358.3,4391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4391,1,3,0)
 ;;=3^707.9
 ;;^UTILITY(U,$J,358.3,4391,1,4,0)
 ;;=4^CHRONIC SKIN ULCER NOS
 ;;^UTILITY(U,$J,358.3,4391,2)
 ;;=^24439
 ;;^UTILITY(U,$J,358.3,4392,0)
 ;;=731.8^^39^355^10
 ;;^UTILITY(U,$J,358.3,4392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4392,1,3,0)
 ;;=3^731.8
 ;;^UTILITY(U,$J,358.3,4392,1,4,0)
 ;;=4^BONE INVOLV IN OTH DIS
 ;;^UTILITY(U,$J,358.3,4392,2)
 ;;=^272681
 ;;^UTILITY(U,$J,358.3,4393,0)
 ;;=V18.0^^39^356^1
 ;;^UTILITY(U,$J,358.3,4393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4393,1,3,0)
 ;;=3^V18.0
 ;;^UTILITY(U,$J,358.3,4393,1,4,0)
 ;;=4^FAM HX-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,4393,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,4394,0)
 ;;=V58.67^^39^356^2
 ;;^UTILITY(U,$J,358.3,4394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4394,1,3,0)
 ;;=3^V58.67
 ;;^UTILITY(U,$J,358.3,4394,1,4,0)
 ;;=4^LONG-TERM USE OF INSULIN
 ;;^UTILITY(U,$J,358.3,4394,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,4395,0)
 ;;=V68.1^^39^356^3
 ;;^UTILITY(U,$J,358.3,4395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4395,1,3,0)
 ;;=3^V68.1
 ;;^UTILITY(U,$J,358.3,4395,1,4,0)
 ;;=4^ISSUE REPEAT PRESCRIPT
 ;;^UTILITY(U,$J,358.3,4395,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,4396,0)
 ;;=V67.59^^39^356^4
 ;;^UTILITY(U,$J,358.3,4396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4396,1,3,0)
 ;;=3^V67.59
 ;;^UTILITY(U,$J,358.3,4396,1,4,0)
 ;;=4^FOLLOW-UP EXAM NEC
 ;;^UTILITY(U,$J,358.3,4396,2)
 ;;=^295581
 ;;^UTILITY(U,$J,358.3,4397,0)
 ;;=249.00^^39^357^17
 ;;^UTILITY(U,$J,358.3,4397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4397,1,3,0)
 ;;=3^249.00
 ;;^UTILITY(U,$J,358.3,4397,1,4,0)
 ;;=4^SEC DM W/O COMP NOT UNCNTRLD
 ;;^UTILITY(U,$J,358.3,4397,2)
 ;;=^336728
 ;;^UTILITY(U,$J,358.3,4398,0)
 ;;=249.01^^39^357^18
 ;;^UTILITY(U,$J,358.3,4398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4398,1,3,0)
 ;;=3^249.01
 ;;^UTILITY(U,$J,358.3,4398,1,4,0)
 ;;=4^SEC DM WO COMP UNCONTRLD
